Range Impac
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Range Impac and buy or sell other stocks, ETFs, and their options commission-free!About RNGE
Range Impact, Inc. engages in unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders. It operates through Pharmaceutical Operations and Clinical Operations segments.
CEOMichael Cavanaugh
CEOMichael Cavanaugh
Employees15
Employees15
HeadquartersCleveland, Ohio
HeadquartersCleveland, Ohio
Founded2007
Founded2007
Employees15
Employees15
RNGE Key Statistics
Market cap16.28M
Market cap16.28M
Price-Earnings ratio11.89
Price-Earnings ratio11.89
Dividend yield—
Dividend yield—
Average volume8.69K
Average volume8.69K
High today$0.1515
High today$0.1515
Low today$0.145
Low today$0.145
Open price$0.145
Open price$0.145
Volume24.25K
Volume24.25K
52 Week high$0.258
52 Week high$0.258
52 Week low$0.09
52 Week low$0.09
Stock Snapshot
With a market cap of 16.28M, Range Impac(RNGE) trades at $0.15. The stock has a price-to-earnings ratio of 11.89.
As of 2025-12-08, Range Impac(RNGE) stock has fluctuated between $0.15 and $0.15. The current price stands at $0.15, placing the stock 0.0% above today's low and -4.3% off the high.
Range Impac(RNGE) shares are trading with a volume of 24.25K, against a daily average of 8.69K.
During the past year, Range Impac(RNGE) stock moved between $0.09 at its lowest and $0.26 at its peak.
During the past year, Range Impac(RNGE) stock moved between $0.09 at its lowest and $0.26 at its peak.